Bellataminal® is triple protection against emotional and autonomic disorders

DOI: https://doi.org/10.29296/25877305-2019-04-07
Download full text PDF
Issue: 
4
Year: 
2019

O. Rubleva, Candidate of Medical Sciences Instamed Medical Center, Domodedovo, Moscow Region

Bellataminal® is a complex drug that contains phenobarbital, belladonna alkaloids, and ergotamine. The total effect of 3 active ingredients contributes to sedation of the central nervous system and the parasympathetic and sympathetic divisions of the autonomic nervous system. This allows the use of Bellatamininal® to correct emotional and autonomic impairments in neurosis-like impairments, somatic diseases, premenstrual and menopausal syndromes. The drug is also used for migraine and a number of other diseases. Most clinical trials have confirmed the efficacy and safety of Bellataminal®.

Keywords: 
neurology
Bellataminal®
phenobarbital
belladonna alkaloids
ergotamine
emotional disorders
autonomic disorders



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Bellataminal® – ofitsial'naja instruktsija po primeneniju, 2013. URL: https://medi.ru [Bellataminal® – ofitsial'naya instruktsiya po primeneniyu, 2013 (in Russ.)].
  2. Bellergal® Spacetabs. URL: https://academic.oup.com
  3. Van der Merwe A. The effect of bellergal and hydergine on the subjective symptoms and the peripheral vasomotor reactions in anxiety states // S. Afr. Med. J. – 1953; 27 (4): 84–8.
  4. Lebherz T., French L. Nonhormonal treatment of the menopausal syndrome. A double-blind evaluation of an autonomic system stabilizer // Obstet. Gynecol. – 1969; 33 (6): 795–9.
  5. Korkina M.V., Lakosina N.D., Lichko A.E. Psihiatrija/M.: Meditsina, 1995; 608 s. [Korkina M.V., Lakosina N.D., Lichko A.E. Psikhiatriya/M.: Meditsina, 1995; 608 s. (in Russ.)].
  6. «Nevroz» i «Nevroticheskoe rasstrojstvo» [«Nevroz» i «Nevroticheskoe rasstroistvo» (in Russ.)] URL: http://doctorspb.ru
  7. Lévêque M. Psychosurgery. Chapter 2: The Neuroanatomy of Emotions/Springer International Publishing, Switzerland, 2014; p. 49–106.
  8. Bellergal® Spacetabs, 2014. URL: http://www.paladin-labs.com
  9. NIIR Board. Herbs Cultivation & Their Utilization/Asia Pacific Business Press Inc., 2003; 522 p.
  10. Rubleva O.V. Obzor literatury po primeneniju preparata Bellataminal® [Rubleva O.V. Obzor literatury po primeneniyu Bellataminala® (in Russ.)] URL: http://www.bellataminal.ru
  11. Maekawa M., Hayase S., Sawami H. et. al. Experiences of the treatments for neurocirculatory asthenia and allied neuroses // Japanese Circ. J. – 1959; 23 (5): 619–32.
  12. Wechsler Z. Autonomic dystonia in the tropics and its treatment // J. Trop. Med. (Hyg.). – 1940; 43: 21.
  13. Tkacheva N.V., Savenkova N.D. Opyt primenenija preparata Bellataminal® u patsientov s zabolevanijami zheludochno-kishechnogo trakta // Rus. med. zhurn. – 2012; 20 (20): 1018–20 [Tkacheva N.V., Savenkova N.D. Opyt primeneniya Bellataminala® u patsientov s zabolevaniyami zheludochno-kishechnogo trakta // Russkii meditsinskii zhurnal. – 2012; 20 (20): 1018–20 (in Russ.)].
  14. Levin O.S., Slizkova Ju.B. Primenenie preparata Bellataminal® v lechenii postkommotsionnogo sindroma // Rus. med. zhurn. – 2012; 20 (8): 417–21 [Levin O.S., Slizkova Yu.B. Primenenie Bellataminala® v lechenii postkommotsionnogo sindroma // Russkii meditsinskii zhurnal. – 2012; 20 (8): 417–21 (in Russ.)].
  15. Understanding PMS, 2016. URL: https://www.healthline.com
  16. Robinson K., Huntington K., Wallace M. Treatment of the premenstrual syndrome // Br. J. Obstet. Gynaecol. – 1977; 84 (10): 784–8.
  17. Andrews J. Vasomotor symptoms: an evidence-based approach to medical management // J. Clin. Outcomes Manage. – 2011; 18 (3): 112–28.
  18. Bernstein A., Simon F. The treatment of cardiovascular symptoms of vasomotor origin // Angiology. – 1958; 9 (4): 197–201.
  19. Bergmans M., Merkus J., Corbey R. et al. Effect of Bellergal Retard on climacteric complaints: a double-blind, placebo-controlled study // Maturitas. – 1987; 9 (3): 227–34.
  20. Miller S., Matharu M. Migraine is underdiagnosed and undertreated // Practitioner. – 2014; 258 (1774): 19–24.
  21. Raskin N., Schwartz R. Interval therapy of migraine: long-term results // Headache. – 1980; 20 (6): 336–40.
  22. Mehvari J., Rafieian-kopaei M. Prophylactic Activity of Cyproheptadine and Bellergal on Migraine Headache // Iran J. Med. Sci. – 2005; 30 (2): 84–7.
  23. Stieg R. Double-blind study of belladonna-ergotamine-phenobarbital for interval treatment of recurrent throbbing headache // Headache. – 1977; 17 (3): 120–4.
  24. Lance J., Curran D., Anthony M. Investigations into the mechanism and treatment of chronic headache // Med. J. Aust. – 1965; 2 (22): 909–14.
  25. Ulbricht C., Basch E., Hammerness P. et al. An evidence-based systematic review of belladonna by the natural standard research collaboration // J. Herb. Pharmacother. – 2004; 4 (4): 61–90.